Lear Corporation (LEA) Stock Forecast
Data as of Jul 31, 2026Consumer Cyclical · Current price $129.61 (-11.04%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 17, 2026 | Edison Yu | Deutsche Bank | $120.00 | -7.4% |
| Feb 5, 2026 | Andrew Percoco | Morgan Stanley | $123.00 | -5.1% |
| Feb 5, 2026 | Dan Levy | Barclays | $140.00 | +8.0% |
| Jan 12, 2026 | Colin Langan | Wells Fargo | $123.00 | -5.1% |
| Dec 8, 2025 | Andrew Percoco | Morgan Stanley | $112.00 | -13.6% |
| Oct 6, 2025 | Joseph Spak | UBS | $106.00 | -18.2% |
| Sep 29, 2025 | Mark Delaney | Goldman Sachs | $104.00 | -19.8% |
| May 6, 2025 | Mark Delaney | Goldman Sachs | $88.00 | -32.1% |
| Oct 30, 2024 | Dan Levy | Barclays | $120.00 | -7.4% |
| Oct 14, 2024 | John Murphy | Bank of America Securities | $170.00 | +31.2% |
| Sep 9, 2024 | Edison Yu | Deutsche Bank | $132.00 | +1.8% |
| May 10, 2024 | Adam Jonas | Morgan Stanley | $160.00 | +23.4% |
| Jun 17, 2022 | Colin Langan | Wells Fargo | $180.00 | +38.9% |
| Apr 25, 2022 | Emmanuel Rosner | Deutsche Bank | $157.00 | +21.1% |
| Apr 10, 2022 | John Murphy | Bank of America Securities | $195.00 | +50.5% |
| Apr 9, 2022 | Itay Michaeli | Citigroup | $154.00 | +18.8% |
| Feb 9, 2022 | Emmanuel Rosner | Deutsche Bank | $197.00 | +52.0% |
| Jan 26, 2022 | Michael Ward | Benchmark Co. | $206.00 | +58.9% |
| Jan 17, 2022 | Emmanuel Rosner | Deutsche Bank | $204.00 | +57.4% |
| Oct 11, 2021 | Chris McNally | Evercore ISI | $220.00 | +69.7% |
Top Analysts Covering LEA
LEA vs Sector & Market
| Metric | LEA | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.75 | 2.50 | 2.42 |
| Analyst Count | 20 | 12 | 19 |
| Target Upside | -5.5% | +132.9% | +18.0% |
| P/E Ratio | 15.90 | 17.41 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $23.54B | $23.61B | $23.72B | 10 |
| 2027-03-31 | $5.96B | $6.07B | $6.19B | 4 |
| 2027-06-30 | $6.28B | $6.40B | $6.52B | 3 |
| 2027-09-30 | $5.60B | $5.70B | $5.81B | 3 |
| 2027-12-31 | $5.94B | $6.05B | $6.17B | 3 |
| 2028-03-31 | $6.16B | $6.28B | $6.40B | 2 |
| 2028-06-30 | $6.27B | $6.38B | $6.51B | 5 |
| 2028-09-30 | $5.86B | $5.97B | $6.08B | 4 |
| 2028-12-31 | $6.14B | $6.26B | $6.38B | 4 |
| 2029-12-31 | $25.39B | $25.72B | $26.23B | 5 |
| 2030-12-31 | $25.78B | $26.11B | $26.63B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $13.84 | $14.42 | $14.90 | 8 |
| 2027-03-31 | $4.13 | $4.23 | $4.34 | 3 |
| 2027-06-30 | $4.46 | $4.57 | $4.68 | 5 |
| 2027-09-30 | $3.55 | $3.63 | $3.72 | 3 |
| 2027-12-31 | $4.34 | $4.45 | $4.56 | 6 |
| 2028-03-31 | $4.55 | $4.66 | $4.78 | 4 |
| 2028-06-30 | $4.89 | $5.01 | $5.14 | 6 |
| 2028-09-30 | $4.44 | $4.55 | $4.67 | 4 |
| 2028-12-31 | $5.21 | $5.33 | $5.47 | 7 |
| 2029-12-31 | $20.95 | $21.31 | $21.86 | 1 |
| 2030-12-31 | $22.23 | $22.60 | $23.19 | 1 |
Frequently Asked Questions
What is the analyst consensus for LEA?
The consensus among 20 analysts covering Lear Corporation (LEA) is Hold with an average price target of $135.57.
What is the highest price target for LEA?
The highest price target for LEA is $220.00, set by Chris McNally at Evercore ISI on 2021-10-11.
What is the lowest price target for LEA?
The lowest price target for LEA is $88.00, set by Mark Delaney at Goldman Sachs on 2025-05-06.
How many analysts cover LEA?
20 analysts have issued ratings for Lear Corporation in the past 12 months.
Is LEA a buy or sell right now?
Based on 20 analyst ratings, LEA has a consensus rating of Hold (2.75/5) with a -5.5% upside to the consensus target of $135.57.
What are the earnings estimates for LEA?
Analysts estimate LEA will report EPS of $14.42 for the period ending 2026-12-31, with revenue estimated at $23.61B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.